GILD
GILEAD SCIENCES, INC.
Key Financials
Gross Profit
$5.9B
↑ 10.8%
Operating Income
$10.0B
↑ 503.0%
Net Income
$8.5B
↑ 1672.9%
Revenue
$29.4B
↑ 2.4%
EPS (Diluted)
$6.78
↑ 1684.2%
Total Assets
$59.0B
↑ 0.0%
Shareholders' Equity
$22.7B
↑ 17.4%
Cash & Equivalents
$5.4B
↑ 1.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GILD |
| Company Name | GILEAD SCIENCES, INC. |
| CIK | 882095 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6505743000 |